Acorn Capital Advisors’s Terns Pharmaceuticals TERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$7.35M Hold
2025
Q1
$5.44M Hold
2024
Q4
$10.9M Buy